Our Life Sciences group is a multi-disciplinary team of more than 90 lawyers drawn from across our global network.
We have a reputation for far-sighted advice to some of the world’s leading life science companies and are described as "an efficient and client-oriented team" in Chambers Global 2010 Life Sciences edition.
Our support for pharmaceuticals, biotech, medical devices, nursing homes and other healthcare-related companies, as well as financial institutions operating in the sector, covers the spectrum: mergers and acquisitions (M&A), commercial transactions, including licensing and collaborations, intellectual property (IP) protection and patent disputes, capital markets and finance, regulatory and private equity.
Our international network enables us to deploy the skills of market-leading experts in a number of jurisdictions and we are well placed to advise on cross-border work, both contentious and non-contentious.
News & insights
Publications: 09 JULY 2021
As an international treaty the Agreement on a Unified Patent Court (UPCA) provides for the establishment of the Unified Patent Court (UPC). As a joint Court of the Contracting Member States, the UPC…Read more
News: 01 JULY 2021
Allen & Overy has boosted its German private equity practice with the appointment of highly regarded private equity specialist Dr Hendrik Röhricht, who is joining the firm’s Munich office as a partner…Read more
Publications: 19 APRIL 2021
After weeks of tough wrangling, the Federal Cabinet has decided to oblige companies throughout Germany to offer coronavirus tests to their employees. This obligation will be included in the SARS-CoV-2…Read more
Publications: 24 NOVEMBER 2020
In the third in our series of webinars, members of Allen & Overy’s Global Employment team discussed the significant issues and challenges that employers need to prioritise in relation to managing and…Read more